Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tami L Mark

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Substance Abuse|March 27, 2019
The importance of identification when measuring performance in addiction treatmentDeborah Garnick, Constance Horgan, Tami L Mark, et al.
Journal of Substance Use and Addiction Treatment|November 23, 2025
Retention among Medicaid beneficiaries in opioid treatment programs in CaliforniaWilliam N Dowd, Daniel H Barch, Tami L Mark, et al.
JAMA Network Open|April 22, 2026
Cascade of Care for Opioid Use Disorder Among Medicaid BeneficiariesThanh T Lu, William N Dowd, Tami L Mark, et al.
BMJ Open|May 4, 2026
Can the GAD-7 be used to create valid, reliable, feasible and actionable outcome-focused paediatric anxiety quality measures for use across specialty and paediatric treatment settings?Tami L Mark, Lissette M Saavedra, Sydney Kirsch, et al.
Psychiatric Services (Washington, D.C.)|April 2, 2019
Cost-Effectiveness of Preventing Depression Among At-Risk Youths: Postintervention and 2-Year Follow-UpFrances L Lynch, John F Dickerson, Gregory N Clarke, et al.
Journal of Substance Abuse Treatment|October 12, 2010
Advancing performance measures for use of medications in substance abuse treatmentCindy Parks Thomas, Deborah W Garnick, Constance M Horgan, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Substance Abuse|March 27, 2019
The importance of identification when measuring performance in addiction treatmentDeborah Garnick, Constance Horgan, Tami L Mark, et al.
Journal of Substance Use and Addiction Treatment|November 23, 2025
Retention among Medicaid beneficiaries in opioid treatment programs in CaliforniaWilliam N Dowd, Daniel H Barch, Tami L Mark, et al.
JAMA Network Open|April 22, 2026
Cascade of Care for Opioid Use Disorder Among Medicaid BeneficiariesThanh T Lu, William N Dowd, Tami L Mark, et al.
BMJ Open|May 4, 2026
Can the GAD-7 be used to create valid, reliable, feasible and actionable outcome-focused paediatric anxiety quality measures for use across specialty and paediatric treatment settings?Tami L Mark, Lissette M Saavedra, Sydney Kirsch, et al.
Psychiatric Services (Washington, D.C.)|April 2, 2019
Cost-Effectiveness of Preventing Depression Among At-Risk Youths: Postintervention and 2-Year Follow-UpFrances L Lynch, John F Dickerson, Gregory N Clarke, et al.
Journal of Substance Abuse Treatment|October 12, 2010
Advancing performance measures for use of medications in substance abuse treatmentCindy Parks Thomas, Deborah W Garnick, Constance M Horgan, et al.
Pageof 13